Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon.
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon.
Alcohol Clin Exp Res. 2019 Feb;43(2):250-261. doi: 10.1111/acer.13938. Epub 2019 Jan 11.
Gestational ethanol (EtOH) exposure is associated with multiple developmental abnormalities, collectively termed fetal alcohol spectrum disorder (FASD). While the majority of women abstain from EtOH following knowledge of pregnancy, one contributing factor to the high FASD prevalence is that pregnancy is not detected until 4 to 6 weeks. Thus, EtOH consumption continues during the initial stages of fetal development.
An experimental protocol is described in which rhesus macaques self-administer 1.5 g/kg/d EtOH (or isocaloric maltose dextrin) prior to pregnancy and through the first 60 days of a 168-day gestation term. Menstrual cycles were monitored, including measurements of circulating estradiol and progesterone levels. The latency to consume 1.5 g/kg EtOH and blood EtOH concentration (BEC) was measured.
Twenty-eight fetuses (14 EtOH and 14 controls) were generated in this study. EtOH did not affect menstrual cycles or the probability of successful breeding. No EtOH-induced gross adverse effects on pregnancy were observed. Individual variability in latency to complete drinking translated into variability in BEC, measured 90 minutes following session start. Drinking latencies in controls and EtOH drinkers were longer in the second gestational month than in the first. All pregnancies reached the planned experimental time point of G85, G110, or G135, when in utero MRIs were performed, fetuses were delivered by caesarean section, and brains were evaluated with ex vivo procedures, including slice electrophysiology. Fetal tissues have been deposited to the Monkey Alcohol Tissue Research Resource.
This FASD model takes advantage of the similarities between humans and rhesus macaques in gestational length relative to brain development, as well as similarities in EtOH self-administration and metabolism. The daily 1.5 g/kg dose of EtOH through the first trimester does not influence pregnancy success rates. However, pregnancy influences drinking behavior during the second month of pregnancy. Future publications using this model will describe the effect of early-gestation EtOH exposure on anatomical and functional brain development at subsequent gestational ages.
妊娠乙醇(EtOH)暴露与多种发育异常有关,统称为胎儿酒精谱系障碍(FASD)。虽然大多数女性在得知怀孕后会停止摄入 EtOH,但导致 FASD 高发病率的一个因素是直到怀孕 4 至 6 周才检测到怀孕。因此,在胎儿发育的初始阶段,仍继续摄入 EtOH。
描述了一项实验方案,恒河猴在怀孕前和 168 天妊娠期中的前 60 天内每天自我给予 1.5g/kg/d EtOH(或等热量麦芽糊精)。监测了月经周期,包括测量循环雌二醇和孕酮水平。测量了摄入 1.5g/kg EtOH 的潜伏期和血液 EtOH 浓度(BEC)。
在这项研究中产生了 28 个胎儿(14 个 EtOH 组和 14 个对照组)。EtOH 并未影响月经周期或受孕成功率。未观察到 EtOH 对妊娠的任何明显不良影响。个体完成饮酒的潜伏期差异导致 BEC 差异,即在会话开始后 90 分钟测量。对照组和 EtOH 饮酒者在妊娠第二个月的饮酒潜伏期比第一个月长。所有妊娠均达到 G85、G110 或 G135 的计划实验时间点,此时进行宫内 MRI 检查,通过剖宫产分娩胎儿,并通过离体程序(包括切片电生理学)评估大脑。胎儿组织已存入猴酒精组织研究资源库。
该 FASD 模型利用了人类和恒河猴在妊娠长度与大脑发育方面的相似性,以及 EtOH 自我给药和代谢方面的相似性。妊娠第一季度每天 1.5g/kg 的 EtOH 剂量不会影响受孕成功率。然而,妊娠会影响妊娠第二个月的饮酒行为。未来使用该模型的出版物将描述早期妊娠 EtOH 暴露对后续妊娠年龄的大脑解剖和功能发育的影响。